LLY

764.43

-0.25%↓

JNJ

153.41

0%↓

ABBV

187.23

-0.07%↓

NVO

72.52

+0.35%↑

UNH

295.54

-1.64%↓

LLY

764.43

-0.25%↓

JNJ

153.41

0%↓

ABBV

187.23

-0.07%↓

NVO

72.52

+0.35%↑

UNH

295.54

-1.64%↓

LLY

764.43

-0.25%↓

JNJ

153.41

0%↓

ABBV

187.23

-0.07%↓

NVO

72.52

+0.35%↑

UNH

295.54

-1.64%↓

LLY

764.43

-0.25%↓

JNJ

153.41

0%↓

ABBV

187.23

-0.07%↓

NVO

72.52

+0.35%↑

UNH

295.54

-1.64%↓

LLY

764.43

-0.25%↓

JNJ

153.41

0%↓

ABBV

187.23

-0.07%↓

NVO

72.52

+0.35%↑

UNH

295.54

-1.64%↓

Search

Fulgent Genetics Inc

Slēgts

SektorsVeselības aprūpe

20.73 -2.36

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

20.66

Max

21.31

Galvenie mērījumi

By Trading Economics

Ienākumi

-5.7M

-12M

Pārdošana

-2.8M

73M

EPS

0.04

Peļņas marža

-16.197

Darbinieki

1,313

EBITDA

-2M

-12M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+12.73% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 1. aug.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

57M

629M

Iepriekšējā atvēršanas cena

23.09

Iepriekšējā slēgšanas cena

20.73

Tehniskais rādītājs

By Trading Central

Pārliecība

Bearish Evidence

Fulgent Genetics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 5. jūn. 20:45 UTC

Peļņas

Broadcom 2Q Sales Climb on Booming AI Demand

2025. g. 5. jūn. 23:45 UTC

Tirgus saruna

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

2025. g. 5. jūn. 23:44 UTC

Tirgus saruna

Gold Edges Higher on Weak U.S. Data -- Market Talk

2025. g. 5. jūn. 23:30 UTC

Tirgus saruna

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

2025. g. 5. jūn. 21:32 UTC

Peļņas

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

2025. g. 5. jūn. 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 5. jūn. 20:45 UTC

Peļņas

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

2025. g. 5. jūn. 20:24 UTC

Peļņas

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

2025. g. 5. jūn. 20:15 UTC

Peļņas

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

2025. g. 5. jūn. 20:15 UTC

Peļņas

Broadcom 2Q Rev $15B >AVGO

2025. g. 5. jūn. 20:15 UTC

Peļņas

Broadcom 2Q Net $4.97B >AVGO

2025. g. 5. jūn. 20:15 UTC

Peļņas

Broadcom 2Q Adj EPS $1.58 >AVGO

2025. g. 5. jūn. 20:15 UTC

Peļņas

Broadcom 2Q EPS $1.03 >AVGO

2025. g. 5. jūn. 20:15 UTC

Peļņas

Broadcom Sees 3Q Rev $15.8B >AVGO

2025. g. 5. jūn. 20:11 UTC

Iegādes, apvienošanās, pārņemšana

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

2025. g. 5. jūn. 20:11 UTC

Iegādes, apvienošanās, pārņemšana

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

2025. g. 5. jūn. 20:11 UTC

Iegādes, apvienošanās, pārņemšana

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

2025. g. 5. jūn. 19:22 UTC

Tirgus saruna

Oil Futures Resume Upward Moves -- Market Talk

2025. g. 5. jūn. 19:00 UTC

Tirgus saruna

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

2025. g. 5. jūn. 18:32 UTC

Tirgus saruna

Gold Slips After Trump-Xi Call -- Market Talk

2025. g. 5. jūn. 18:26 UTC

Peļņas

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

2025. g. 5. jūn. 18:06 UTC

Tirgus saruna

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

2025. g. 5. jūn. 16:30 UTC

Iegādes, apvienošanās, pārņemšana

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

2025. g. 5. jūn. 16:20 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 5. jūn. 16:18 UTC

Tirgus saruna

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

2025. g. 5. jūn. 16:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2025. g. 5. jūn. 16:12 UTC

Tirgus saruna

Global Energy Roundup: Market Talk

2025. g. 5. jūn. 16:12 UTC

Tirgus saruna

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

2025. g. 5. jūn. 16:03 UTC

Tirgus saruna

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

2025. g. 5. jūn. 15:49 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

Fulgent Genetics Inc Prognoze

Cenas mērķis

By TipRanks

12.73% augšup

Prognoze 12 mēnešiem

Vidējais 24 USD  12.73%

Augstākais 25 USD

Zemākais 23 USD

Pamatojoties uz 2 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Fulgent Genetics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

2 ratings

1

Pirkt

1

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

17.32 / 19.04Atbalsts un pretestība

Īstermiņā

Bearish Evidence

Vidējā termiņā

Strong Bullish Evidence

Ilgtermiņā

Neutral Evidence

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Fulgent Genetics Inc

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.